Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Drinking extra water combined with lemon juice might prevent encrustation of long-term indwelling urinary catheters, sparing patients from urinary retention or incontinence due…
NEW YORK (Reuters Health) – Drug-eluting stents in saphenous vein grafts have a lower risk of revascularization than bare-metal stents, according to a meta-analysis of data on nearly…
NEW YORK (Reuters Health) – Patients with the H1N1 virus who started oseltamivir in the first 3 days of illness had shorter periods of viral shedding, according to…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – A new biomarker – tumor-associated CD68+ macrophages — predicts poor outcomes in patients with classic Hodgkin’s lymphoma, new research indicates. About 20% of…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
NEW YORK (Reuters Health) – A normal coronary artery calcium (CAC) scan in middle-age appears to have a “warranty period” of about four years, during which the patient…
NEW YORK (Reuters Health) – With small breast cancers, doing complete axillary dissections only for positive sentinel lymph node biopsies (SNLB) yields the same 10-year survival – roughly…
NEW YORK (Reuters Health) – Use of insulin glargine or detemir rather than NPH insulin does not reduce the risk of ketoacidosis in children and adolescents with type…
